Dilek DÜLGER, Mustafa TÜRK, Selim YALÇINª, Feray AYDIN, Özgür ALBUZ, Beste ÇAĞDAŞ TUNALI

Effects of B2O3 (boron trioxide) on colon cancer cells: our first-step experience and in vitro results

Boron oxide (B2O3) is derived from dehydration of boric acid and is a colorless, semitransparent, crystalline compound thatis moderately soluble in water. On the other hand, boron oxide is chemically hygroscopic. This gives the molecule the ability to soakup water and adhere to tissues. Boron oxide can be used locally after tumor debulking in inoperable tumors and especially when thetumor-free margin distance cannot be provided. For all these reasons we aimed to evaluate the in vitro test results of B2O3 in termsof cytotoxicity, genotoxicity, apoptosis, and necrotic effects on L929 fibroblast cells and DLD-1 colorectal adenocarcinoma cells. Ourstudies demonstrated that boron oxide compounds appear to be highly cytotoxic for both cell lines according to WST cell viability assay(44.22% and 18.36% on DLD-1 and L929, respectively). Although no genotoxic effects were observed, boron oxide compounds showedantiproliferative effects for both cell lines. The prepared boron oxide compounds may hold the potential to be applied locally to theremaining tissue after surgery and further research and evaluation will be needed to determine its effectiveness.

PDF

___

Adams J, Behnke M, Chen S, Cruickshank AA, Dick LR et al. (1998). Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorganic & Medicinal Chemistry Letters 8: 333-338.
AICR (2018). Colorectal Cancer Statistics. Arlington, VA, USA: American Institute for Cancer Research. Baker SJ, Ding CZ, Akama T, Zhang YK, Hernandez V et al. (2009). Therapeutic potential of boron-containing compounds. Future Medicinal Chemistry 1: 1275-1288.
Bergsbaken T, Fink SL, Cookson BT (2009). Pyroptosis: host cell death and inflammation. Nature Reviews Microbiology 7: 99.
Chattopadhyay N, Berger AJ, Koenig E, Bannerman B, Garnsey J et al. (2015). KRAS genotype correlates with proteasome inhibitor ixazomib activity in preclinical in vivo models of colon and non-small cell lung cancer: potential role of tumor metabolism. PLoS one 10: e0144825.
Cunningham CC (2007). Talabostat. Expert Opinion on Investigational Drugs 16: 1459-1465. Demir C (2007). Bor minerallerinin enerji kaynağı olarak değerlendirilmesi. MSc, Selçuk University, Konya, Turkey (in Turkish)
Dobrydneva Y, Blackmore P (2001). 2-Aminoethoxydiphenyl borate directly inhibits store-operated calcium entry channels in human platelets. Molecular Pharmacology 60: 541-552.
Ediz N, Özdağ H (2001). Bor mineralleri ve ekonomisi. Dumlupınar Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2001: 133-151 (in Turkish). EFSA (2013). Scientific opinion on the re‐evaluation of boric acid (E 284) and sodium tetraborate (borax) (E 285) as food additives. EFSA Journal 11: 3407.
Engür S, Dikmen M (2017). The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib. Acta Clinica Belgica 72: 391-398.
Feng M, Feng J, Chen W, Wang W, Wu X et al. (2016). Lipocalin 2 suppresses metastasis of colorectal cancer by attenuating NFκB-dependent activation of snail and epithelial mesenchymal transition. Molecular Cancer 15: 77.
Fischer AH, Jacobson KA, Rose J, Zeller R (2008). Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protocols 2008: pdb.prot4986.
Geniş B, Coşar B (2018). Mania associated with the use of bortezomib and dexamethasone. Turk Psikiyatri Dergisi 29: 209-215 (in Turkish with abstract in English). Gilbert B, Perfetti L, Fauchoux O, Redondo J, Baudat PA et al. (2000).
Spectromicroscopy of boron in human glioblastomas following administration of Na2 B12H11SH. Physical Review E 62: 1110.
Glynn SJ, Gaffney KJ, Sainz MA, Louie SG, Petasis NA (2015). Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3- gallate and related polyphenols. Organic & biomolecular Chemistry 13: 3887-3899.
Jansen K, Heirbaut L, Cheng JD, Joossens J, Ryabtsova O et al. (2013). Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold. ACS Medicinal Chemistry Letters 4: 491-496.
Kahraman G (2004). Bor Nötron Yakalama Tedavisinde Kullanılan Hızlandırıcıya Dayalı Nötron Kaynakları. Ankara, Turkey: Türkiye Atom Enerjisi Kurumu, Teknoloji Dairesi (in Turkish). Kocakuşak S (1994). Microwave processing of boric acid to produce granular boron oxide. In: 5th International Symposium on Progress in Mineral Processing Technology, pp. 487-491.
Li X, Wang X, Zhang J, Hanagata N, Wang X et al. (2017). Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment. Nature Communications 8: 13936. Midgley R, Kerr D (1999). Colorectal cancer. Lancet 353: 391-399.
Nedunchezhian K, Aswath N, Thiruppathy M, Thirugnanamurthy S (2016). Boron neutron capture therapy-a literature review. Journal of Clinical and Diagnostic Research 10: ZE01. Nelson RS, Thorson AG (2009). Colorectal cancer screening. Current Oncology Reports 11: 482-489.
NIH (2019). Compound Summary for CID 518682, Boric Oxide. Open Chemistry Database. Bethesda, MD, USA: National Center for Biotechnology Information.
Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE et al. (2018). Inhibition of Dpp8/9 activates the Nlrp1b inflammasome. Cell Chemical Biology 25: 262-267.
Pekol T, Daniels JS, Labutti J, Parsons I, Nix D et al. (2005). Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites. Drug Metabolism and Disposition 33: 771-777.
Ramis G, Martinez-Alarcon L, Quereda JJ, Mendonça L, Majado M et al. (2013). Optimization of cytotoxicity assay by real-time, impedance-based cell analysis. Biomedical Microdevices 15: 985-995.
Richardson PG, Hideshima T, Anderson KC (2003). Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers. Cancer Control 10: 361-369.
Rocca A, Marino A, Del Turco S, Cappello V, Parlanti P et al. (2016). Pectin-coated boron nitride nanotubes: In vitro cyto-/immunecompatibility on RAW 264.7 macrophages. Biochimica et Biophysica Acta - General Subjects 1860: 775-784.
Sendler M, Mayerle J, Lerch MM (2016). Necrosis, apoptosis, necroptosis, pyroptosis: it matters how acinar cells die during pancreatitis. Cellular and Molecular Gastroenterology and Hepatology 2: 407-408.
Singh B, Kaur G, Singh P, Singh K, Kumar B et al. (2016). Nanostructured boron nitride with high water dispersibility for boron neutron capture therapy. Scientific Reports 6: 35535. Smoum R, Rubinstein A, Dembitsky VM, Srebnik M (2012). Boron containing compounds as protease inhibitors. Chemical Reviews 112: 4156-4220.
Sugarbaker PH (1999). Successful management of microscopic residual disease in large bowel cancer. Cancer Chemotherapy and Pharmacology 43: S15-S25.
Sun S, Li W, Zhang H, Zha L, Xue Y et al. (2012). Requirement for store-operated calcium entry in sodium butyrate-induced apoptosis in human colon cancer cells. Bioscience Reports 32: 83-90.
Tait SW, Ichim G, Green DR (2014). Die another way–non-apoptotic mechanisms of cell death. Journal of Cell Science 127: 2135- 2144.
Taşgın Y (2018). Katalizör olarak katılan bor oksit ve borik asidin polyester üzerindeki etkilerinin mekanik ve mikroyapı açısından incelenmesi. Fırat Üniversitesi Mühendislik Bilimleri Dergisi 30: 303-311 (in Turkish).
Trumbo P, Yates AA, Schlicker S, Poos M (2001). Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Journal of the Academy of Nutrition and Dietetics 101: 294.
Urcan E, Haertel U, Styllou M, Hickel R, Scherthan H et al. (2010). Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dental Materials 26: 51-58.
Wada Y, Hirose K, Harada T, Sato M, Watanabe T et al. (2018). Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy. Journal of Radiation Research 59: 122-128.
WHO (1998). Boron in Drinking-Water Report. Geneva, Switzerland: WHO.
Yakıncı ZD, Kök M (2016). Borun sağlık alanında kullanımı. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi 4: 36-44 (in Turkish).